GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: compound 20 [WO2020259584]
Compound class:
Synthetic organic
Comment: Soficitinib is the INN for a Janus kinase inhibitor with anti-inflammatory potential (included in WHO INN proposed list 133, 10th July 2025). The chemical structure is claimed as compound No. 20 in patent WO2020259584A1 (Guangzhou Innocare Pharma), and as a TYK2 (Janus kinase subtype) inhibitor [1]. Innocare have two TYK2 inhibitors in their development pipeline: ICP-332, an oral TYK2-JH1 (catalytic domain) inhibitor for eczema/atopic dermatitis [2], and ICP-488, an oral TYK2-JH2 (allosteric) inhibitor for psoriasis. The structures for these two inhibitors have not been disclosed (July 2025).
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel